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Abstract
Background: Inhalation exposure studies of mice were conducted to determine if multi-walled carbon nanotubes
(MWCNT) distribute to the tracheobronchial lymphatics, parietal pleura, respiratory musculature and/or
extrapulmonary organs. Male C57BL/6 J mice were exposed in a whole-body inhalation system to a 5 mg/m3
MWCNT aerosol for 5 hours/day for 12 days (4 times/week for 3 weeks, lung burden 28.1 ug/lung). At 1 day and
336 days after the 12 day exposure period, mice were anesthetized and lungs, lymph nodes and extrapulmonary
tissues were preserved by whole body vascular perfusion of paraformaldehyde while the lungs were inflated with
air. Separate, clean-air control groups were studied at 1 day and 336 days post-exposure. Sirius Red stained sections
from lung, tracheobronchial lymph nodes, diaphragm, chest wall, heart, brain, kidney and liver were analyzed.
Enhanced darkfield microscopy and morphometric methods were used to detect and count MWCNT in tissue
sections. Counts in tissue sections were expressed as number of MWCNT per g of tissue and as a percentage of
total lung burden (Mean ± S.E., N = 8 mice per group). MWCNT burden in tracheobronchial lymph nodes was
determined separately based on the volume density in the lymph nodes relative to the volume density in the
lungs. Field emission scanning electron microscopy (FESEM) was used to examine MWCNT structure in the
various tissues.
Results: Tracheobronchial lymph nodes were found to contain 1.08 and 7.34 percent of the lung burden at 1 day
and 336 days post-exposure, respectively. Although agglomerates account for approximately 54% of lung burden,
only singlet MWCNT were observed in the diaphragm, chest wall, liver, kidney, heart and brain. At one day post
exposure, the average length of singlet MWCNT in liver and kidney, was comparable to that of singlet MWCNT in
the lungs 8.2 ± 0.3 versus 7.5 ± 0.4 um, respectively. On average, there were 15,371 and 109,885 fibers per gram in
liver, kidney, heart and brain at 1 day and 336 days post-exposure, respectively. The burden of singlet MWCNT in
the lymph nodes, diaphragm, chest wall and extrapulmonary organs at 336 days post-exposure was significantly
higher than at 1 day post-exposure.
Conclusions: Inhaled MWCNT, which deposit in the lungs, are transported to the parietal pleura, the respiratory
musculature, liver, kidney, heart and brain in a singlet form and accumulate with time following exposure. The
tracheobronchial lymph nodes contain high levels of MWCNT following exposure and further accumulate over
nearly a year to levels that are a significant fraction of the lung burden 1 day post-exposure.
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Background
With the wide spread development of commercial carbon
nanotube manufacturing and commercial application, car-
bon nanotubes (CNT) such as MWCNT are an important
category of nanoparticle for health risk assessment. There
is a need to address the associated bioactivity of these
newly manufactured materials. Initial studies focused on
the respiratory effects of pulmonary exposure but were
limited by the lack of knowledge concerning the occupa-
tional levels. Ongoing studies of environments where
worker exposure may occur are providing the necessary
data to provide realistic inhalation exposures necessary for
health risk assessments [1].
MWCNTaspiration exposures in mice conducted at lung
burdens relevant to measured occupational exposures have
demonstrated early dose- and time-dependent pulmonary
inflammation and damage [2]. MWCNT aerosol exposures
have demonstrated a variety of effects such as thickening of
the alveolar septa [3], severe airway fibrosis in sensitized
mice [4], and diffuse histiocytic and neutrophilic in-
flammation with persistent pulmonary inflammation
and granulomas [5].
The small size, lipophilic nature and reported occur-
rence in the visceral pleura and pleural space [2,6-8] indi-
cate that MWCNT may disseminate elsewhere in the
body following pulmonary exposure. Interest in detection
of this potential extrapulmonary transport has been in-
creased by reports demonstrating extrapulmonary effects
of CNT in the brain [9] and cardiovascular system [10-12]
as well as demonstrations that CNT have genotoxic effects
[13] and activate several carcinogenic-related signaling
pathways [14].
Traditional studies of extrapulmonary transport have
been based on detection of a tracer label, typically radio-
active [15-17], fluorescent [18,19] or a unique elemental
form such as colloidal gold [20] which can be detected
by inductively couple plasma mass spectrometry or neu-
tron activation studies. The limits of detection for these
methods are typically set either by the instability of the
tracer label, instrument sensitivity or the elemental na-
ture of the tracer. For instance, neutron activation ana-
lysis has detection limits ranging from a few micrograms
per gram of tissue to nanogram levels [21,22]. Detection
limits by neutron activation depend on suitable elemen-
tal composition and are a function of the element and
background interference. While potentially very sensi-
tive, these methods do not generally allow microscopic
visualization of individual particles or particle-tissue
interactions.
Developments in microscope technology such as
enhanced darkfield microscopy allow the direct detec-
tion and imaging of singlet CNT. Enhanced darkfield
microscopy has been applied for detection and analysis
of nanoparticles within the lungs from a variety of
exposure [23-25]. We have recently applied enhanced
darkfield microscopy techniques to detection of MWCNT
in extrapulmonary organs following a 1 day inhalation ex-
posure. That study demonstrated MWCNT translocation
to extrapulmonary organs, detecting MWCNT in all the
extrapulmonary organs sampled (liver, kidney and heart)
within 24 hours of exposure [26] In this report, we
extended those observations to a chronic post-exposure
study to include a more extensive sampling of sites includ-
ing the tracheobronchial lymph nodes, the diaphragm,
chest wall and brain in addition to the liver, kidney and
heart. In addition, we compared the distribution in these
sites at 1 day and 336 days after the termination of
exposure in order to determine if there was a significant
accumulation of MWCNT in systemic tissue with time
post-exposure.
Results
FESEM was used to examine MWCNT structures in the
lungs and other tissues of this study. Figure 1 shows ex-
amples of MWCNT structures in the lungs and kidney.
The top two micrographs (Figure 1A and 1B) show
MWCNT structures in an alveolar macrophage and the
alveolar interstitial space, respectively. As we have previ-
ously demonstrated, alveolar macrophages and the inter-
stitial space are the two principal sites for lung burden
following inhalation exposure [27]. The surface of the
alveolar macrophage in Figure 1A shows numerous
protruding MWCNT fibers with white arrows indicating
protruding singlets, and multiple MWCNT fibers protrud-
ing from the surface indicated by the black arrow at 1 day
post-exposure. The black arrow in Figure 1B shows a mul-
tiple fiber MWCNT structure just beneath the alveolar
epithelium (black arrow) and a singlet MWCNT in the
alveolar interstitium (white arrow) at 336 days post-
exposure. An example of a singlet MWCNT in the kidney
at 336 days post-exposure is shown in Figure 1C with a
lower magnification inset indicating the singlet’s position
within Bowman’s capsule of the kidney shown by the dark
rectangle in the lower left of the micrograph. No systemic
pathology was noted in tissue sections used to quantify
MWCNT translocation.
As illustrated by the representative, enhanced darkfield
images of tracheobronchial lymph nodes in Figure 2,
there were significant accumulation of and changes in
the distribution of MWCNT fibers within the lymph
nodes between 1 and 336 days exposure. At 1 day post-
exposure MWCNT fibers in the tracheobronchial lymph
nodes were generally singlet MWCNT or small MWCNT
agglomerates which were widely scattered throughout
the cortex. With increasing days after exposure, foci of
phagocytic cells were associated with dense clusters of
nanotubes within the tracheobronchial lymph nodes.
Translocation of MWCNT from the lung to the
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tracheobronchial lymph node has previously been dem-
onstrated in rats [28]. In the mouse, we have previously
described MWCNT translocation to the tracheobron-
chial lymph nodes after acute MWCNT inhalation [27].
After acute exposure, the MWCNT in the lymph node
were predominantly localized to the deep paracortical
region within cells morphologically consistent with
macrophages and dendritic cells. Cells containing both
MWCNT and apoptotic debris are also observed. In
addition to similar changes noted in our previous acute
Figure 1 FESEM examples of MWCNT in lung and kidney tissue sections after MWCNT inhalation exposure. FESEM image of alveolar
macrophages 1 day post-exposure in Figure 1A shows typical examples of MWCNT fibers protruding from the surface of alveolar macrophages
(black arrow multiple fibers, white arrows singlets). Examples of MWCNT found in the alveolar interstitial space are shown in Figure 1B (336 day
post-exposure). The image of a kidney section in Figure 1C shows a typical example of the single MWCNT found in extrapulmonary organs
(336 day post-exposure). The location of this MWCNT singlet within Bowman’s capsule of the kidney is shown by the black rectangle given in the
low magnification insert in the lower left of the figure.
Figure 2 Enhanced dark-field images of tissue sections from tracheobronchial lymph nodes 1 and 336 days after MWCNT inhalation
exposure. As typified by the micrograph, at 1 day post-exposure singlet MWCNT fibers were observed scattered throughout sections of lymph
nodes. However, 336 days post-exposure, numerous dense concentrations of MWCNT fibers were found within the lymph nodes. MWCNT fibers
are bright white in these enhanced darkfield images due to scattering of light by MWCNT, while cell nuclei are brownish red and other tissue
elements are green.
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inhalation study, the tracheobronchial lymph nodes at
336 days were enlarged by 70% above their clean-air
counterparts, dark gray in their appearance due to the
accumulation of MWCNT and contained the foci of
dense MWCNT aggregates noted above.
Examples of the enhanced darkfield images of MWCNT
fibers in the diaphragm, kidney and brain at 1 day and
336 days after inhalation exposure are given in Figure 3.
MWCNT fibers detected in the diaphragm, chest wall and
extrapulmonary organs were with rare exceptions, singlets.
In these tissues, approximately one in 200 MWCNT
structures were doublets. The nearly exclusive observa-
tion of singlet MWCNT in diaphragm, chest wall and
extrapulmonary organs was in contrast to the observa-
tions of dense, large MWCNT structures observed at
336 days post-exposure in the tracheobronchial lymph
nodes (Figure 2). At 336 days post-exposure, the con-
centration of fibers in diaphragm and extrapulmonary
organs (Table 1) was significantly higher than at one
day post-exposure. At 336 days post-exposure, singlet
MWCNT were detectable in nearly all 40x fields of view
in sections of liver and kidney with multiple, but sepa-
rated, fibers detected in the same field of view as shown in
the figure for the kidney. Average fiber length was 8.4 ±
0.3 and 8.8 ± 0.3 um at 1 and 336 days post-exposure in
extrapulmonary organs (Mean ± S.E., N = 100). In the
lungs, average fiber length of singlets was 8.2 ± 0.3 and
7.5 ± 0.4 um at 1 and 336 days post-exposure (N = 100).
Analysis demonstrated that singlet MWCNT were
present in lavage of the pleural space from MWCNT-
exposed mice at 336 days post-exposure. Figure 4 shows
an example of same singlet MWCNT in the lavage fluid
as visualized by light and enhanced darkfield micros-
copy. MWCNTs in the pleural lavage were singlets with
an average length of 6.9 microns. Singlet MWCNTs in
the lavage of the pleural space were found either in close
contact or penetrating into the cytoplasm and/or nucleus
of monocytes in the pleural lavage. There was approxi-
mately 1 singlet MWCNT per 3000 cells in the pleural
lavage. This is comparable to the 1 crocidolite fiber per
Figure 3 Enhanced darkfield images of MWCNT fibers in the diaphragm, kidney and brain at 1 day and 336 days after inhalation
exposure. MWCNT fibers in these figures are bright white, cell nuclei are brownish red and other tissue elements are green. With rare exceptions,
MWCNT fibers detected in extrapulmonary organs were singlets. Normal (transmitted) light was blended into the fields and contrast adjusted to
make the tissue histology of the organs visible in these photographs.
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4000 cells in pleural lavage reported for an inhalation ex-
posure study of asbestos-induced pleural injury in rats
[29]. Based on counting cytocentrifuge slides of the 1 ml
pleural lavage fluid there was an average of 23.7 ± 7.6
(Mean ± S.E., N = 5) singlet MWCNT, in the lavage of the
pleural space. Pleural lavage at 1 day post-exposure was
not conducted.
The light micrograph of the same singlet MWCNT on
the left side of Figure 4 was only visible over a narrow
range of focus and was very difficult to identify even
though nearby cells, visible in enhanced darkfield im-
aging, were clearly visible in the light microscope. The
exercise of identifying singlet MWCNT in lavage fluid
from the pleural space, and the example of side-by-side
Table 1 Extrapulmonary MWCNT concentration, number






% of lung burden2
1 Lymph Nodes 0.03 508,776,984 14,263,560 1.08000
Liver 1.53 25,767 39,303 0.00281
Kidney 0.45 16,639 7,438 0.00105
Heart 0.12 11.849 1,371 0.00022
Brain 0.38 7,231 2,776 0.00101
Chest Wall 1.00 13,774 13,764 0.00354
Diaphragm 0.07 6,767 507 0.00025
Total% 1.089%
336 Lymph Nodes 0.05 1,807,273,684 84,845,500 7.30000
Liver 1.83 196,798 360,456 0.02740
Kidney 0.54 126,973 68,165 0.00520
Heart 0.14 62,401 8,670 0.00070
Brain 0.46 53,569 24,740 0.00190
Chest Wall 1.07 10,382 12,457 0.00090
Diaphragm 0.09 59,915 5,392 0.00040
Total% 7.337%
1Body weights of MWCNT exposed mice were 22.9 ± 0.5 and 40.5 ± 2.2 g at 1 day and 336 days post-exposure, respectively.
2100 × Total number of fibers in organ divided by 1 day post-exposure lung burden of 1,321 million fibers per lung.
Figure 4 Light and enhanced darkfield micrographs of MWCNTs detected in lavage of pleural space. The figure shows a comparison of
the light and enhanced darkfield image of a singlet MWCNT in lavage of the pleural space in mice at 336 days post-exposure.
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comparison of enhanced darkfield versus light micros-
copy of MWCNT structures containing a few or singlet
MWCNT structures indicate that enhanced darkfield is
the optimal instrument for scanning of wide fields to de-
tect nanoparticles. Based on side-by-side comparisons,
the transmitted light microscope is not a reliable tool for
identification of these MWCNT structures.
Results from morphometric analysis of MWCNT fi-
bers in tracheobronchial lymph nodes, diaphragm, chest
wall and extrapulmonary organs are shown in Figure 5.
At 1 day post-exposure, the content of MWCNT fibers
in the tracheobronchial lymph nodes was principally in
the form of singlets or a few fibers per MWCNT struc-
ture and accounted for 1.08% of the lung burden 1 day
post-exposure. MWCNT structures in tracheobronchial
lymph nodes at 336 days included foci with dense accu-
mulations with the content being substantially increased
and equal to 7.34% of the lung burden 1 day post-
exposure. MWCNT were only rarely observed in exam-
ination of the adventitia attached to the node capsules.
The high level of MWCNT burden delivered to the
tracheobronchial lymph nodes was approximately 300
times greater than the burden delivered to the liver which
was the highest observed in extra-pulmonary organs.
Total MWCNT burden for diaphragm, chest wall and
extrapulmonary organs was 0.009 and 0.037 percent of
lung burden at 1 day and 336 days, respectively, after
exposure. By 336 days post-exposure there was a 6 to
7-fold increase in the concentration of MWCNT in
extrapulmonary organs and diaphragm, excluding the
chest wall. MWCNT in the chest wall did not change
significantly over this period.
The chest wall, which had a concentration of fibers
comparable to that of the overall median concentration
for extrapulmonary organs at 1 day post exposure did
not accumulate fibers with time post-exposure as was
observed for other organs. At the same time, the dia-
phragm, which is the other major pleural opposed surface,
demonstrated an approximate 7-fold increase similar to
the other organs examined. The chest wall, unlike other
tissues, was decalcified prior to embedding and sectioning.
This difference in treatment could be responsible. To test
for a treatment effect, weighed samples of the MWCNT
were treated extensively with the decalcification solution
in the same manner as the chest wall tissue and then
washed, dried and reweighed. In FESEM examination of
the formic acid-treated MWCNT fibers, no apparent
degradation due to the treatment was observed. Average
length of MWCNT fibrils in the chest wall section was
not significantly different than that of the diaphragm
which was not decalcified with formic acid.
In Table 1 are given the organ weights, concentration of
MWCNT fibers per gram of tissue, total MWCNT fibers
in each tissue and the percentage relative to the lung bur-
den at 1 day post-exposure for the tracheobronchial lymph
nodes, diaphragm, chest wall and extrapulmonary organs.
Excluding the lymph nodes and respiratory muscles, the
concentrations at 1 day post-exposure varied by a factor of
four with the highest concentration in the liver at 25,767
fibers/g and the lowest in the brain at 7,231 fibers/g. At
Figure 5 Percentage of 1 day post-exposure lung burden detected in tracheobronchial lymph nodes, extrapulmonary organs,
diaphragm and chest wall. By 336 days post-exposure there was a 7-fold increase in MWCNT in extrapulmonary organs and diaphragm over
that measured at 1 day post-exposure. Categories of extrapulmonary organs are ordered relative to MWCNT concentration in the respective
tissue. Asterisks indicate significantly different between day 1 and 336 days post-exposure, p < 0.05.
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1 day post-exposure the order in terms of fibers per gram
was liver, kidney, heart, and brain with the liver concentra-
tion being significantly elevated above the other organs.
This does not appear to follow the order that is found in
the distribution of blood flow per ml min-1 g-1 which has
been reported to be heart, kidney, brain and liver based on
radiolabeled microspheres in anesthetized mice [30]. En-
hanced uptake of MWCNT by the reticuloendothelial
system of the liver, fenestrated endothelium of the kidney
and restricted uptake due to the blood–brain-barrier in
the brain may account for these differences between organ
blood flow and MWCNT uptake.
Discussion
Recent developments in microscope technology, such as
enhanced darkfield microscopy, allow the direct detec-
tion and imaging of singlet CNT. The ability to detect a
single fiber in a large tissue section affords a very high
detection limit. For instance, a typical animal inhalation
exposure at 5 mg/m3 contains 1.4 × 1010 particles [31].
On average, a singlet MWCNT fiber of this aerosol
would weigh 0.4 picograms. A typical section from a
mouse is approximately 2 cm by 2 cm by 0.0005 cm
deep or 0.002 cm3. Assuming the detection limit is one
fiber per section, identification of a singlet MWCNT in
a tissue section represents the ability to detect less than
a nanogram of fibers per gram of tissue. Enhanced
darkfield microscopy has been applied for detection and
analysis of nanoparticles within the lungs from a variety of
exposure [23-25]. In the present study, based on Table 1,
the percentage of lung burden transported to the dia-
phragm at 1 day post-exposure was 0.00025 percent. This
is equivalent to detection of 3 singlet MWCNT in the
diaphragm for every million MWCNT fibers initially
deposited in the lungs.
We have previously shown that exposure to MWCNT
results in significant fiber accumulations within the
interstitial spaces of the lungs, the lymphatics and the
visceral pleura [2,6,27,32]. The MWCNT structures
within these sites were generally composed of single fibers
or structures containing a few fibers, while MWCNT
structures with a greater number of fibers remained in the
airspaces and within alveolar macrophages of the lungs.
The present study extends those results to demonstrate
that MWCNT deposited in the lungs are transported to
the pleura and/or extrapulmonary organs. The magnitude
of extrapulmonary transport can be evaluated by express-
ing the lung burden transported in terms of fiber number
translocated to the extrapulmonary organs (liver, kidney,
hear and brain) relative to the initial number of fibers
deposited in the lungs at 1 day post-exposure. Expressing
the results of Table 1 in that manner, approximately 1 fiber
deposits in an extrapulmonary organ for every 25,700
MWCNT fibers of lung burden present in the lungs at
1 day post-exposure after a 12 day exposure period. Trans-
port during the post-exposure period from 1 day to 336 days
significantly elevated the accumulation in extrapulmonary
tissues with approximately 1 fiber for every 2,800 fibers
present in the lungs at 1 day post-exposure being
transported to extra-pulmonary tissues.
The significance of these levels of transport depends
on the critical target for health risk assessment. At the
cellular level, the mouse lung [33] and liver [34] contain
approximately 119 billion and 15 billion cells, respectively.
Dividing these cell numbers by the respective fiber counts
(Table 1) demonstrates that, in the lungs, at 1 day post-
exposure there is approximately 1 MWCNT fiber per 90
lung cells. In the liver at 1 day post-exposure, there is ap-
proximately 1 fiber per 381,650 liver cells and 1 fiber per
41,600 liver cells at 336 days post-exposure. These results
clearly demonstrate that mass-action effects such as fibro-
sis are unlikely in extrapulmonary organs at these levels of
transport. On the other hand, recent studies [13] have
demonstrated that MWCNT fibers have highly efficient
mutagenic effects which could prove to be a health risk
concern for neoplastic development.
Donaldson et al. [35] raised concern that high aspect ra-
tio CNT may, like asbestos, induce mesothelioma. Indeed,
Takagi et al. [36] reported that intraperitoneal injection of
MWCNT (3 ug/mouse) led to mesothelioma of the ab-
dominal wall. Murphey et al. [37] reported persistent
inflammation and fibrosis of the parietal pleural surface
24 weeks after intrapleural injection of long (>15 um) but
not short (<4 um) MWCNT (5 ug/mouse). Therefore,
there is great interest in determining whether pulmonary
exposure to MWCNT leads to migration of MWCNT into
the pleura, quantifying the magnitude of this migration,
and determing if pleural lesions result. Ryman-Rasmussen
et al. [8] reported MWCNT in subpleural lung tissue after
inhalation exposure in mice. Porter et al. [2] were the first
to demonstrate that such subpleural MWCNT can pierce
the surface of the lungs and enter the intrapleural space
after aspiration of these nanoparticles. Mercer et al. [6]
conducted quantitative microscopic morphometry of lung
tissue from the Porter et al. study and reported 12,000
penetrations of MWCNT into the intrapleural space
2 months after aspiration of MWCNT (80 ug/mouse). The
current study extends these results in the following man-
ner: 1) lungs were exposed to MWCNT by inhalation of
mice over 12 days to yield a lung burden of 28 ug/lung,
2) morphometric analysis of chest wall and diaphramattic
tissue was conducted at 1 and 336 days post-exposure,
and 3) the number of MWCNT in the ches wall and dia-
phragm was quantified. Results indicate that at 336 days
after inhalation exposure 12,457 fibers were found in the
chest wall while 5,292 fibers were found in the diaphragm.
Whether this fiber burden in pleural tissue results in in-
flammation, lesions and/or transformation of mesothelial
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cells is currently being investigated in an ongoing inhal-
ation study at NIOSH.
Recently, Schinwald et al. [38] determined the threshold
fiber length which would result in pleural inflammation
1 week after intrapleural injection of silver nanofibers of
well defined lengths. Results showed a distinct length
threshold, with fibers longer than 4 um leading to a patho-
genic response. The MWCNT fibers aerosolized in the
current study have a mean length of 4.3 um [31]. Of inter-
est, singlet MWCNT found in the chest wall, diaphragm,
and systemic tissue appear to be in the 7–8 um range. Al-
though these fibers should be too short to cause frustrated
phagocytosis, they appear to be long enough to be retained
in the pleura as demonstrated for MWCNT harvested by
pleural lavage 336 days post-exposure (Figure 4).
Therefore, if the pleural burden is sufficiently high a
pathogenic response may be expected.
The route by which MWCNT are transported to the
extra-pulmonary cannot be directly determined from the
results of this study. Given the low levels found in the
extrapulmonary organs a number of routes are possible.
Phagocytosis of MWCNT by circulating monocytes/
macrophages and neutrophils which transiently passage
via the circulation, may provide a significant route. Ob-
servation of MWCNT loaded circulating cells in the ca-
pillary bed of extrapulmonary organs would be expected
if phagocytosis or other adherence to MWCNT in the
lungs resulted in transport to extrapulmonary organs.
The nearly exclusive transport of singlet MWCNT to
extrapulmonary organs (Figures 1 and 3) suggests that
this route is not significant. Specific attempts were made
to identify MWCNT in cells within the hepatic sinuosoids
of the liver but none were detected. However, cases which
demonstrated singlet MWCNT apparently at, or within,
the endothelial boundary of capillaries were observed. An
example is shown by the singlet MWCNT in the nearly
tangential section through a capillary of the brain in the
lower right panel of Figure 3.
MWCNT cleared from the lungs via the macrophage-
mucociliary escalator may be reabsorbed by the gastro-
intestinal tract. In whole-body inhalation exposures, which
was the exposure method in our study, intestinal absorp-
tion of MWCNT ingested during preening of fur may also
be a significant pathway. Reports on the contribution by
gut absorption to systemic delivery of nanoparticles have
come to differing results. Kreyling et al. [16] found less
than 1 percent of deposited nanoparticles transported to
systemic organs and did not find evidence for gut absorp-
tion of 15 or 80 nm radio-labeled iridium particle when
comparing extrapulmonary transport by whole body inhal-
ation, gavage and intratracheal instillation. In a subsequent
study by this group, using radiolabelled ultrafine carbon
particles, Oberdörster et al. [17] found significant trans-
port to the liver in whole body exposures of the rat and
concluded that differences in translocation between the
different nanoparticles may reflect differences in chemistry
of the particles or gut absorption.
Finally the tracheobronchial lymphatic are a major route
for fluid exchange of the lungs. Macrophage mediated
transport through the lymphatic network has been shown
to be important in particulate clearance from the lungs
[39]. The high lymphatic burdens observed 1 day post-
exposure and at 336 days post-exposure (Table 1, Figures 2
and 4) indicate that the transport of MWCNT thru the
lymphatics and ultimately into the venous circulation
may be a major route for systemic delivery of MWCNT.
Consistent with this role, dilation of peribronchiolar
lymphatics was noted in the present study, as well as
our previous acute inhalation exposures [27]. However,
direct measurements of MWCNT in the venous outflow
from the lymphatics will be necessary to demonstrate
the potential significance of this route.
Conclusions
One day after a 12 day inhalation exposure period
MWCNT fibers were found throughout a wide range
of lung associated tissues (lymph nodes, chest wall,
diaphragm) and in extrapulmonary organs. Over the
post-exposure period of 336 days, the lymph nodes accu-
mulated a substantial fraction of 1 day post-exposure lung
burden, while the levels in extrapulmonary organs in-
creased approximately 6 to 7 fold. Inhaled MWCNT are
capable of wide-spread dissemination and accumulation
throughout the body. Outside the lungs and tracheobron-
chial lymph nodes the levels of accumulation are not likely
to pose a risk of fibrosis. However, by 336 days post-
exposure, the concentration of MWCNT per gram of tra-
cheobronchial lymph nodes exceeds that in the lungs and
is likely to produce adverse reactions, as those reported
previously after exposure of mice by aspiration [2].
The slow rate at which MWCNT are cleared from the
lungs by normal macrophage-mediated processes coupled
with the high concentration in the tracheobronchial lymph
nodes and the chronic accumulation in extrapulmonary
organs and pleural associated tissue clearly demonstrate
the need to address concerns about potential extra-




Male C57BL/6 J mice (7 weeks old) were obtained from
Jackson Laboratories (Bar Harbor, ME). Mice were
housed one per cage in polycarbonate ventilated cages,
which were provided HEPA-filtered air, with fluorescent
lighting from 0700 to 1900 hours. Autoclaved Alpha-Dri
virgin cellulose chips and hardwood Beta-chips were
used as bedding. Mice were monitored to be free
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of endogenous viral pathogens, parasites, mycoplasms,
Helicobacter and CAR Bacillus. Mice were maintained
on Harlan Teklad Rodent Diet 7913 (Indianapolis, IN),
and tap water was provided ad libitum. Animals were
allowed to acclimate for at least 5 days before use. All
animals used in this study were housed in an AAALAC-
accredited; specific pathogen-free, environmentally con-
trolled facility. All animal procedures were approved by
the NIOSH ACUC.
Carbon nanotube source
MWCNT used in this study were obtained from Hodogaya
Chemical Company (MWNT-7, lot #061220-31) and were
manufactured using a floating reactant catalytic chemical
vapor deposition method followed by high thermal treat-
ment in argon at 2500°C furnace. This lot of MWCNT
was fully characterized in our prior report in which acute
inhalation exposures were conducted with this lot of
MWCNT [27]. Briefly, MWCNT trace metal contamin-
ation was 1.32%, with iron (1.06%) being the major metal
contaminants. The bulk MWCNT were analyzed using
several different techniques; 1) high resolution TEM, 2)
XPS, and 3) electron spin resonance spectroscopy and are
described in detail [27]. Bulk and aerosol MWCNT
morphology, were also analyzed by TEM and SEM in that
study and found to have a similarity in particle shape and
configuration to those collected from the breathing zones
of a MWCNT manufacturing workplace [40].
MWCNT aerosol generation and aerosol characterization
Mice were exposed to a MWCNT aerosol (5 mg/m3,
5 hours/day) for 12 days, using an acoustical-based com-
puter controlled system designed and constructed by
our laboratory [41]. Details of the exposure system, aerosol
control performance and aerosol characterization have
previously been published [27]. In brief, the inhalation
exposure system combines air flow controllers, aerosol
particle monitors, data acquisition devices, and custom
software with automated feedback control to achieve con-
stant and repeatable exposure chamber temperature, rela-
tive humidity, pressure, aerosol concentration, and particle
size distributions. The generator produces airborne parti-
cles continuously for long periods of time, e.g. 35 hours of
continuous operation, with minimal fluctuations during
an exposure period. The uniformity of test atmosphere
in the chamber was evaluated to have a total variation
of < 5%. In this study, the MWCNT aerosol mass con-
centration was continuously monitored with a Data
RAM (DR-40000 Thermo Electron Co, Franklin, MA),
and gravimetric determinations (37 mm cassettes with
0.45 μm pore-size Teflon filters) were used to calibrate
and verify the Data RAM readings. The mass mode
aerodynamic diameter was 1.3 μm with a count mode
aerodynamic diameter of 0.42 μm [27]. When characterized
by lognormal statistics, the distribution was shown to have
a mass median aerodynamic diameter (MMAD) of 1.5 μm
and a geometric standard deviations (GSD) of 1.67 [27].
In the prior acute MWCNT inhalation study, run con-
currently with this chronic study, the MWCNT lung bur-
den in the mouse at 1 day post-exposure was determined
to be 28.1 ug/lung [27]. Workplace MWCNT-containing
airborne dust levels of approximately 400 μg/m3 have
been reported in a research laboratory [40] while a later
study reported the highest total particle concentration of
320 μg/m3 with a mean of 106 μg/m3 based on results
obtained from monitoring total workplace dust levels at
seven MWCNT facilities [42]. Assuming a level of one-
tenth of the reported workplace range (10–40 ug/m3)
Porter et al. [27] demonstrated that human worker expos-
ure to MWCNT, performing light work for approximately
8.5 years in a work environment would be expected to
produce a similar concentration of MWCNT in terms of
micrograms per square meter of alveolar epithelial surface
area in the human worker lungs as this inhalation study
produced in the mouse lung. Thus the current mouse
exposure represents an approximate feasible human occu-
pational exposures.
Pleural lavage
Lavage of the pleural space was conducted prior to the
instillation of fixative in an additional group of mice at
336 days post-exposure and in a corresponding clean-air
group. Mice were deeply euthanized with an i.p. injection
of sodium pentobarbital (>100 mg/kg body weight). For
pleural lavage, a midline incision of the abdomen was made
and a small cut made in the diaphragm. A blunted plastic
tube connect to a 1 ml syringe was then used to slowly
infuse and withdraw 1 ml of ice cold Ca2+ and Mg2+-free
phosphate buffered saline, pH 7.4, supplemented with
5.5 mM D-glucose (PBS) into the pleural space 5 times.
Slides were prepared from 0.2 ml aliquots using a cyto-
centrifuge (Shandon Elliot Cytocentrifuge, London). The
cytospin preparations were stained with modified Wright-
Giemsa stain and MWCNT fibers counted by scanning
the entire sample at 60x magnification with an enhanced
darkfield microscope.
Lung fixation and section preparation
At 1 day and 336 days after the 12 day exposure
period, mice were euthanized by an overdose of pento-
barbital (>100 mg/kg body weight, i.p.) and lungs and
extrapulmonary tissues were preserved by whole body
vascular perfusion of paraformaldehyde while the
lungs were inflated with air. Separate, clean-air control
groups were studied.
For whole body perfusion the trachea was cannulated,
the lungs inflated with 1 ml of air and a midline incision
of the chest was made to expose the heart and lungs.
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The left ventricle of the heart was punctured with a large
bore needle connected to a reservoir 100 cm above the
chest wall of the animal. In quick sucession the right
atrium was cut, to allow outflow, the reservoir valve was
opened to allow perfusion of the whole body with clear-
ing solution (heparinized saline). After the clearing solu-
tion was passed (2 to 5 ml), the reservoir was switched
to paraformaldehyde and the whole body perfusion fixed
(~ 25 to 50 ml).
Following fixation the tracheobronchial lymph nodes,
diaphragm, heart, kidney, liver and brain were removed,
and sliced into 5–6 mm thick tissue blocks and embedded
in paraffin. The left lung was removed, cut into a coronal
mid-section and processed independently to avoid poten-
tial for contamination. The chest wall was decalcified in
formic acid prior to embedding. Sections (5 micron thick)
were collected on ultrasonically cleaned, laser cut slides
(Schott North America, Inc, Elmsford, N.Y. 10523) to
avoid nanoparticle contamination from the ground edges
of traditional slides. To enhance the contrast between tis-
sue and MWCNT, sections were stained with Sirius Red.
Sirius Red staining consisted of immersion of the slides in
0.1% Picrosirius solution (100 mg of Sirius Red F3BA in
100 ml of saturated aqueous picric acid, pH 2) for 1 hour
followed by washing for 1 minute in 0.01 N HCl. Sections
were then briefly counterstained in freshly filtered Mayer’s
hematoxylin for 2 minutes, dehydrated, and coverslipped.
For serial section analysis to determine the mean caliper
diameter of MWCNTs in tissue, five serial sections of the
lungs (3 um thick) were collected on one slide and stained
as described above.
Field emission scanning electron microscopy
For scanning electron microscopy, sections of the lung
were cut at 8 microns, placed on carbon planchets,
deparaffinized and sputter coated. After coating, the speci-
mens were examined with a Hitachi Model S-4800 Field
Emission Scanning Electron Microscope (FESEM) at 5 to
10 kV and at working distances of 4.5 mm to 6 mm for
magnifications of 100,000× to 1000×, respectively. Photo-
graphs were taken in slow scanning mode at 1280 × 1024
pixels. Use of thin sections from paraffin embedded tissue
was found to be preferable to large, unevenly cut blocks
because it provided a uniform thickness of organic mater-
ial on the carbon planchet. The 8 micron sections were
thick enough to convey three-dimensional information
but were also less likely to charge or undergo physical
shifts when examined at the high magnifications necessary
to study nanomaterials.
Enhanced-darkfield light microscopy imaging of
nanoparticles
Carbon nanotubes in sections from exposed lungs were
assessed using an enhanced-darkfield optical system.
Using this method of imaging, lung sections can be
easily scanned at relatively low magnification to identify
CNTs that would not be detected by other means.
Nanomaterials, such as carbon nanotubes, have dimen-
sions less than the wavelength of light, have closely
packed atoms, and typically have a refractive index sig-
nificantly different from that of biologic tissues and/or
mounting medium. These characteristics produce signifi-
cantly greater scattering of light by nanoparticles than by
the surrounding tissues. The enhanced-darkfield optical
system images light scattered in the section and, thus,
nanomaterials in the section stand-out from the surround-
ing tissues with high contrast. Detection of a nanomaterial
in a section thus depends on the ability of the particle to
scatter light and the number of scattered photons required
for detection by the imaging system.
In practice enhanced darkfield has been found to be
an essential tool to detect and measure MWCNT re-
gional pulmonary distribution [32] and in detection of
MWCNT systemic transport following inhalation in
the rat [26]. Detection and quantitiatve assessment of
other nanoparticles has been reported. These include
the diesel fuel catalyst, cerium oxide [23], titanium di-
oxide nanospheres [24], titanium dioxide nanospheres
and nanobelts [25] and summarized in a review article
on pathologic assessment of nanoparticles which de-
scribes aspects of enhanced darkfield in nanoparticle
detection [43].
The optical system for enhanced darkfield microscopy
consisted of high signal-to-noise, darkfield-based illumin-
ation optics adapted to an Olympus BX-41 microscope
(CytoViva, Auburn, AL 36830). Sections for dark-field
examination were specifically cut from paraffin blocks and
collected on ultrasonically cleaned, laser cut slides (Schott
North America Inc, Elmsford, N.Y. 10523) to avoid nano-
particle contamination from the ground edges of trad-
itional slides. After staining with Sirius Red-Hematoxylin,
sections were coverslipped with Permount. After align-
ment of the substage oil immersion optics with a 10x
objective, sections were examined with 60x or 100x oil
immersion objectives. Enhanced darkfield images were
taken with a 2048 × 2048 pixel digital camera (Dage-MTI
Excel digital camera XLMCT, Michigan City, In 46360).
Number of MWCNT fibers in diaphragm, chest wall and
extrapulmonary organs
Measurement of the distribution of MWCNT to the dia-
phragm, chest wall and extrapulmonary organs was made
at 1 day and 336 days after the 12 day exposure period by
counting the number of fibers in sections of diaphragm,
chest wall and extrapulmonary organs. These counts of
fibers per unit area were converted to number per organ
using the mean caliper diameter of the fibers to convert
from fibers per unit area to fibers per unit volume using
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the same morphometric methods as previously reported
for counting of granulomas [44], alveoli [45], and cells/
nuclei [33,46]. Use of mean caliper diameter to convert
from number per unit area to number per unit volume in
a shape independent and unbiased fashion was originally
described by Hillard [47]. As illustrated in Table 2, the
number of fibers was converted to number per unit area
by dividing the counts by the area of the respective sec-
tion. To determine the number of fibers per unit volume,
the number per unit area was divided by the mean caliper
diameter (4.5 and 4.2 um for 1 and 336 days post-
exposure, respectively) plus section thickness (5 um). Re-
sults were expressed as number per gram assuming a unit
density of 1 g/cm3 for tissue. Mean caliper diameter was
measured by taking serial sections and measuring the
length of the fiber projection in the z-axis.
Sections of clean-air control lungs were scanned as well
for fibers but were negative for the presence of MWCNT
fibers. Total MWCNT fiber number of 1,321 million was
used for the lung based on previously reported measure-
ments of 1 day post-exposure lung burden of MWCNT
fibers of 28.1 ug/lung previously determined for this
inhalation study [27] and a conversion of 47 million
MWCNT fibers per ug [24].
Measurement of singlet MWCNT fiber length in lungs, liver
and kidney
Optical sectioning through a series of serial sections in
lung, liver and kidney was used to measure the length of
singlet MWCNT at 1 and 336 days after the termination
of inhalation exposure. Serial sections consisted of 4–5
sections, 5 um thick, mounted on a single slide. For each
tissue/series (lungs or systemic organs) the second sec-
tion of each series was scanned for singlet MWCNT
using enhanced darkfield illumination with a high nu-
merical aperture, 100x oil immersion objective. When a
singlet MWCNT was identified in the second section, it
was selected for measurement if it did not continue
down into the first section to produce an unbiased
(length independent) sampling. Thus singlet MWCNT
were selected for measurement if they began in the sec-
ond section. In the second section of each selected sing-
let, the lower-most end was focused on, photographed
and the depth (Z co-ordinate on focus knob) recorded.
A point mid-fiber in the section (or at a sharp bend/
inflection point if present) was next focused, photographed
and the depth (Z co-ordinate) recorded. Finally, the upper-
most end of the singlet was focused on, photographed and
the depth (z co-ordinate) recorded. If the singlet continued
in the adjacent upper section(s) the process of focus, pho-
tography and Z-co-ordinate measurement was repeated to
the end of the singlet. ImageJ was then used to measure
the X-Y co-ordinates of the singlet/middle points. The
length of the singlet was then calculated from the 3-
dimensional distance from one end through the middle to
the other end (including adjacent sections if the singlet
was not completely contained within a section). Approxi-
mately 20 singlet MWCNT were measured in each lung,
liver and kidney in 5 animals at 1 and 336 days after the
inhalation exposure.
Measurement of MWCNT content in tracheobronchial
lymph nodes
Direct counting of MWCNT in tracheobronchial lymph
nodes was not possible due to the dense aggregations
beyond 1 day post-exposure. Instead, the volume density
of MWCNT relative to the volume density of MWCNT in
the lung at 1 day post-exposure was used to determine the
lymph node content. For this purpose, 6–12 photographs
were taken at 60x uniformly distributed across the mid-
section profile of the capsule of each lymph node and
across the mid-section of the left lung. Each section was
thresholded to produce white for MWCNT and black for
air/tissue and the volume proportion determined using
ImageJ. The accuracy of this procedure was verified by
direct comparison of a sample of photograph to manual
point counting which produced volume densities for
MWCNT that were within 1% of the threshold image de-
termined values. The mass of MWCNT in the tracheo-
bronchial lymph nodes was then obtained by multiplying
the lung burden times the ratio of volume densities, which
was then multiplied by the ratio of tracheobronchial
lymph node volume to lung volume.
Direct weighing of the tracheobronchial lymph nodes
was not suitable to determine the capsule volume of the
nodes where MWCNT were found. Unlike extrapulmonary
organs, dissected tracheobronchial lymph nodes have a
high mass of associated adventitia which cannot be
removed without risk of damage to the nodes where
the MWCNT are concentrated. To avoid injury to the
capsule, which was also needed for pathological assess-
ment, the entire dissected tracheobronchial lymph
node was embedded and a mid-block tissue section
photographed. The area of the capsule of the tracheo-
bronchial lymph nodes was then used to calculate the
organ weight assuming a tissue density of 1 gm/cm3.
Table 2 Formula for number of singlet MWCNT in organ
Na Number per unit area cm
2
D Mean caliper diameter of singlet MWCNT cm
T Section thickness cm
V Organ Volume = Organ Weight gm × 1 cm3/gm
NV Number per unit volume #/ cm
3
NO Number per organ
NV = Na/(D+T).
NO = NV × V.
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Statistical analyses
Data were analyzed using analysis of variance (STATGRAF).
Bartlett’s test was used to test for homogeneity of variances
between groups. Statistical differences were determined
using one-way analysis of variance with significance set
at p ≤ 0.05. When significant F values were obtained, in-
dividual means at 336 days post-exposure were com-
pared to corresponding 1 day post-exposure for the
corresponding organ using Duncan’s multiple range test
[48], and P < 0.05 was considered to be significant. Data
are given as Means ± S.E.
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